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Introduction
Cryptococcal meningitis (CM) is the most common systemic 
fungal infection in patients with HIV infection. Globally, 
there are an estimated 181,100 estimated deaths from CM, 
with 75% of  the deaths occurring in sub-Saharan Africa 
(SSA)1. Despite the increased coverage of  antiretroviral 
treatment (ART) programs in high burden countries, the case 
fatality rate of  CM remains high at 35%–65% in SSA2–4. In 
Malawi, studies have reported that more than 40% of  patients 
diagnosed with CM die within 4 weeks of  the diagnosis, 
and that 55%–58% die by 10 weeks5,6. Consequently, early 
diagnosis and the timely initiation of  antifungal therapy is 
essential if  we are to reduce morbidity and mortality from 
cryptococcal disease. 
The clinical presentations of  CM are often indistinguishable 
from other causes of  meningitis. As such there is a need for 
a more accurate and robust diagnostic test for the diagnosis 
of  CM7. The laboratory diagnosis of  CM includes direct 
visualization of  cryptococci via microscopy, culture of  the 
organism and/or the detection of  cryptococcal antigens in 
cerebrospinal fluid (CSF). Even though India ink is rated 
poorly in terms of  diagnostic ability for CM, and with 
regards to sensitivity and specificity8–11, evidence indicates 
that India ink stain is still widely used for the detection of  
cryptococci in CSF, particularly in resource-limited countries 
such as Malawi12. 
Although cell culture is relatively slow, it is still considered 
to represent the gold standard for CM diagnosis. Antigen 
detection is rapid, and is associated with high sensitivity 
(93%–100%) and specificity (93%–98%); however, this form 
of  detection is not available in low-resource countries due 
to its excessive costs10. Therefore, microscopy continues to 
be widely adopted as a rapid, cheap and reliable diagnostic 
method in these settings. 
There are few published data on the utility of  the Gram 
stain for the direct detection of  cryptococci in CSF samples, 
particularly in patients infected with HIV. Furthermore, there 
is little published data available that compares microscopic 
and antigen-based CM diagnostic methods, particularly in 
resource-constrained settings such as Malawi. We therefore 
undertook a comparative evaluation of  Gram stain, India 
ink stain, and two forms of  lateral flow assay (LFA) (Immy 
and Dynamiker), for the rapid diagnosis of  cryptococcal 
meningitis in HIV-infected patients in Mzuzu, Malawi. 
Abstract
Introduction
Cryptococcal meningitis (CM) is the most common systemic fungal infection in patients with HIV infection. Rapid diagnosis and 
timely initiation of  antifungal therapy are key to reducing mortality rate associated with CM. This study aims to evaluate the ability of  
four different diagnostic tests (Gram stain, India ink, and two types of  commercial lateral flow assay [LFA]) to identify CM-positive 
patients and to compare the sensitivity and specificity of  these tests.
Methods
This was a prospective cross-sectional study on diagnostic tests accuracy conducted in Northern Malawi. The target population was 
HIV-infected adult patients presenting with features of  meningitis. Four types of  diagnostic tests were conducted: India ink, Gram 
stain, and two types of  commercial lateral flow assay (LFA) (Immy, Inc., OK, USA and Dynamiker Biotechnology (Tianjin) Co., Ltd), 
Singapore). Culture was conducted as the reference standard.
Results
A total of  265 samples were collected. The rate of  positive CM detection ranged from 6.4% (using India ink) to 14.3% (using LFA). 
India ink exhibited the lowest sensitivity of  54.8% (95% confidence interval [CI]: 36.0%–72.7%), followed by Gram stain (61.3%; 95% 
CI: 42.2%–78.2%). The Dynamiker LFA exhibited the highest sensitivity of  100.0% (95% CI: 90.0%–100.0%) but a lower specificity 
(97.0%; 93.9%–98.8%) compared to the Immy LFA (98.3%; 95% CI: 95.7%–99.5%). 
Conclusion
LFA diagnostic methods have the potential to double the detection rate of  CM-positive patients in resource-limited countries such 
as Malawi. As such, LFAs should be considered to become the main diagnostic tests used for CM diagnostics in these countries. Our 
data indicate that LFAs may be the best method for diagnosing CM and exhibits the highest diagnostic accuracy as it has shown that it 
outperforms cell culture, the current gold standard. 
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The main objectives of  the study were to: (1) establish the 
detection rate of  positive-CM patients among HIV-infected 
patients presenting with features of  meningitis in Mzuzu 
Central Hospital by using different diagnostic methods, and 
(2) compare the sensitivity and specificity of  the Gram stain, 
India ink and two LFA tests for the diagnosis of  CM.
Methods
Study design
This was a prospective cross-sectional study relating to the 
accuracy of  diagnostic tests for CM conducted at Mzuzu 
Central Hospital, Northern Malawi. 
Setting
Mzuzu Central Hospital is a government tertiary hospital 
located in the northern part of  Malawi that serves a 
population of  about 2.5 million13. As a tertiary institution, 
this hospital is a referral site for all secondary and private 
hospitals in northern Malawi. The hospital also serves as a 
secondary health care facility for Mzimba North District due 
to the lack of  a district hospital.
Participants
This study targeted HIV-infected patients in the hospital. 
The specific inclusion criteria were males and females aged 
18 years or more, presenting with features of  meningitis 
(fever, headache, confusion, neck stiffness, photophobia and 
vomiting). Potentially eligible participants were identified by 
clinicians in the outpatient department and inpatient wards. 
Patients were excluded if  they refused to provide consent 
and/or were taking fungal treatment, or had any history of  
fungal treatment.
Sampling method
This was a hospital-based study and we considered the 
sample size to consist of  all patients who attended the 
hospital during the study period (10 months) who fulfilled 
the inclusion criteria. Patients with fever, headache, 
confusion, neck stiffness, photophobia and vomiting, and 
who were also HIV-positive were included in the study. The 
participants were recruited in a consecutive series until a 
sample size of  265 was reached; this sample size met the 
minimum requirement for this type of  study, as indicated in 
the literature14–16. 
Laboratory test methods
Cryptococcus species were identified by morphological, 
biochemical and serological characteristics. Four types of  
diagnostic tests were conducted on the samples, including: the 
India ink test, Gram stain, and two types of  commercial LFAs 
(Immy, Inc. OK, USA; Dynamiker Biotechnology (Tianjin) 
Co., Ltd). CSF was collected from participants following 
aseptic standard procedures used in the hospital. Microscopy 
techniques were then used to carry out morphological tests 
to identify cryptococcus directly from the CSF using India 
ink staining and Gram staining; these tests were carried out in 
accordance with established standard operating procedures 
(SOPs)14. In the India ink test, the polysaccharide capsule 
does not take up the stain, resulting in the appearance of  
a refractile large white circle against a dark background. 
For the Gram stain, cryptococci appear as single, budding, 
thin-walled, oval to round cells containing gram-positive 
granular inclusions, surrounded by a capsule that varies in 
size and appears to be gram-negative. Characteristically, 
the attachment between the parent and daughter cell is 
extremely narrow, and a lattice formation is evident within 
a cluster of  cryptococci. Immunochromatographic assays 
were employed for the serological detection of  cryptococcal 
capsular polysaccharide antigen in CSF. This was performed 
in accordance with the manufacturer’s recommendations. 
An immunochromatographic assay allows the detection of  
a target analyte in a specific sample. The selection of  the 
commercial platform was based on the manufacturer’s claims 
relating to high specificity, sensitivity and the availability of  
the test kits within the country.
The culture method was used as a reference standard; this 
methodology represents the gold standard for CM diagnosis 
at present. CSF sediments were cultured on Sabouraud 
dextrose agar (SDA) for 48–72 hours according to an 
established SOP (MZCH317) at Mzuzu Central Hospital 
Laboratory. Sabouraud media supports fungal growth. We 
also added a broad-spectrum antibiotic (chloramphenicol 
or tetracycline) to the media to inhibit the growth of  gram-
positive and gram-negative bacteria. Further identification 
was based on biochemical tests, mainly Niger seed agar 
and urease test production. The process used for sample 
collection and testing is shown in Figure 1.
Quality assurance
Culture media, gram reaction and the potency of  antimicrobial 
discs were checked against standardized reference strains of  
Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 
25923). Mzuzu Central Hospital Laboratory, Microbiology 
Department participates in the UK NEQAS and Zimbabwe 
National Quality Assurance Programme (ZIMQAP) external 
quality assurance schemes. Both positive and negative 
controls were also included on a weekly basis for the LFA 
and on a daily basis for microscopic tests and culturing. 
Data variables and collection
A case report form was developed to capture data variables 
related to patient demographic characteristics, chief  
complaints and symptoms, and HIV status. Laboratory test 
results were extracted from the log book in the Microbiology 
Department with a structured proforma. Patient privacy and 
confidentiality was guaranteed as numbers were used for the 
identification of  participants instead of  names. Electronic 
data were protected using a password known only to the 
investigators. Data collection was performed from May 2017 
to July 2018. 
Statistical analysis
Data recorded on the case report form and structured 
proforma were subsequently entered into a spreadsheet. 
Data management and analysis were performed using 
Microsoft Excel. The 95% confidence intervals (CIs), which 
are important for diagnostic accuracy, were determined using 
MedCalc software15 
Ethics approval
Permission to carry out the study was obtained from the 
hospital management research and publication committee. 
Ethical approval was obtained from the Malawi National 
Health Science Research Committee in Lilongwe, Malawi 
(approval number: NHSRC #17/01/1718). 
Results
A total of  265 samples were collected from eligible 
participants. All samples were tested using the four diagnostic 
methods and by routine cell culture (Figure 2). Among the 
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Figure 3 shows the rate of  positive-CM identification 
according to the different diagnostic tests. The rate of  
positive-CM identification ranged from 6.4% (using India 
ink) to 14.3% (using LFA). Both LFA tests identified more 
positives than the conventional culture method, our reference 
standard. The Dynamiker LFA produced the highest rates 
of  positivity, while India ink produced the lowest rates of  
positivity, identifying only approximately half  of  the number 
of  cases as the culture method. 
A comparison of  the diagnostic methods with respect to 
sensitivity, specificity and accuracy, is shown in Table 2. India 
ink and Gram stain were associated with the lowest sensitivity 
(54.8% and 61.3%) but the highest specificity (100%) in the 
diagnosis of  CM. Both LFA tests showed 100% sensitivity 
and high specificity of  up to 98.3%, with the Immy LFA 
exhibiting the highest level of  accuracy (98.5%).
Discussion
A positive fungal culture is the gold standard for the diagnosis 
of  cryptococcal infection. Previous research has shown that 
samples of  CSF show fungal growth in almost all cases of  
CM10,12,16. However, due to problems associated with delay 
and the critical demand of  expertise, fungal culture may not 
be the most favourable diagnostic method for the clinical 
management of  CM. Furthermore, in situations like Malawi, 
in which the burden and prevalence of  CM is low, there is 
a possibility that the culture method may not identify every 
case of  CM. 
In this study, the Gram stain was found to be marginally more 
sensitive (61.3%) than the India ink stain (54%), although 
this difference was not tested for statistical significancy. Our 
findings show lower levels of  sensitivities for the Gram stains 
as compared to other studies12,17. In most studies, India ink 
has been reported to have a lower  sensitivity rate compared 
to Gram stain and demands greater levels of  expertise than 
the Gram stain11,12. Although subjective, a study conducted 
in Durban, South Africa by Coovadia et al.12, reported 
the outcomes of  a brief  interview held with a number of  
laboratory technologists; the consensus was that the Gram 
study participants, there were more male than females (55.5% 
and 45.5%, respectively), and the majority were between 30 
and 39 years old (Table 1). 
LFA, lateral flow assay.
Figure 1: Sample flow analysis
CM, cryptococcal meningitis; LFA, lateral flow 
assay.
Figure 2: Flow of participant (Laboratory results based)
Figure 3: The rate of positive-CM detection by different laboratory 
diagnostic methods.
Table 1. Demographic characteristics





<20 9 (7.6) 8 (5.4) 17 (6.4)
20–29 35 (29.7) 29 (19.7) 64 (24.2)
30–39 34 (28.8) 49 (33.3) 83 (31.3)
40–50 28 (23.7) 41 (27.9) 69 (26.0)
>50 12 (10.2) 20 (13.6) 32 (12.1)
Total 118 (100.0) 147 (100.0) 265 (100.0)
Table 2. Comparison of the sensitivity, specificity, and 
accuracy, of four laboratory diagnostic methods for 
cryptococcal meningitis






India ink 54.8 (36.0–72.7) 100.0 (98.5–100.0) 95.0 (91.7–97.2)
Gram stain 61.3 (42.2–78.2) 100.0 (98.5–100.0) 95.7 (92.6–97.8)
Immy LFA 100.0 (90.0–100.0) 98.3 (95.7–99.5) 98.5 (96.2–99.6)
D y n a m i k e r 
LFA
100.0 (90.8–100.0) 97.0 (93.9–98.8) 97.4 (94.8–99.0)
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blinding of  results in this study; this may affect the results 
arising from the Gram stain and India ink tests, since they 
are more subjective. However, the technicians used in the 
present study were not aware of  the intention to determine 
sensitivity and specificity; hence we believe that the tests 
were interpreted in the way that they would be interpreted in 
a routine clinical setting. 
Conclusion
Our research found that the Gram stain was more sensitive 
than the India ink stain for the detection of  CM. However, 
LFA was clearly the best method for diagnosing CM, and 
showed the highest levels of  sensitivity and specificity. They 
also outperform cell culture, the current gold standard. 
LFA diagnostic methods have the potential to double the 
detection rate of  CM-positive patients in resource-limited 
countries such as Malawi. 
As such, LFAs may be considered to be the main diagnostic 
tests used for CM diagnostics in these countries 
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